Valeria Yartseva

Valeria Yartseva, Ph.D. is Associate Director for Translational Biology at Ryne Bio. She was recently Principal Scientist of Neuroscience Discovery at BridgeBio Pharma leading multiple early discovery programs to develop Antisense Oligonucleotide (ASO) and small molecule therapies for neurodegenerative diseases. Previously, she was a Scientist in the Neuroscience Department at Genentech where she led research programs across neuromuscular indications including Duchenne Muscular Dystrophy, cell replacement therapy, and ALS. She received her PhD from Yale University and BA in Neuroscience from UC Berkeley.